Bio-Techne Corp
NASDAQ:TECH
| Market Cap (Intraday) | 11.86B |
| Current PE | 70.57 |
| Forward PE | 40.42 |
| 2yr Forward PE | 34.46 |
| 10-Day MA | $76.51 |
| 50-Day MA | $75.21 |
| 200-Day MA | $73.56 |
Bio-Techne Corp Stock, NASDAQ:TECH
614 McKinley Place NE, Minneapolis, Minnesota 55413-2610
United States of America
Phone: +1.612.379.8854
Number of Employees: 3100
Description
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.